Article Tools/Herramientas de artículos
+ Larger Font/Fuente más grande | - Smaller Font/Fuente más pequeña






Consumer News Why Are Prescription Drugs So Much More Expensive In The Us

Search Related Content

Sorry, Your Requested Page Was Not Found. Greetings! We apologize for the inconvenience, but the page, Consumer News Why Are Prescription Drugs So Much More Expensive In The Us is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3-18 months after their creation date. We prefer to keep content fresh and current, rather than holding onto outdated news. Thanks for visiting today.
Search RobinsPost News & Noticias


Consumer News Why Are Prescription Drugs So Much More Expensive In The Us | RobinsPost News & Noticias

Why Are US Drug Prices So High? Can Trump Really Make Them Cheaper?


Americans spend more on prescription drugs than anyone else in the world. It’s true that they take a lot of pills. But what really sets the US apart is how much drugs cost. Unlike in most other ... Read More

Patients may not gain much from Trump drug price deals


The Trump administration portrays its deals with drug manufacturers as major victories against rising drug prices — but they won't have a huge impact on most consumers' wallets. Why it matters: Tying ... Read More

Direct-to-consumer drug pricing could compete with prescription insurance


A new study offers a glimpse at how direct-to-consumer pharmacy pricing could one day present stiff competition to the private prescription drug insurance model, researchers say. A team led by ... Read More

Direct-To-Consumer Sales Can Fulfill Trump’s Drug Pricing Promises


Forbes contributors publish independent expert analyses and insights. Sally Pipes is a scholar and think tank CEO who writes on health care. "The White House would be wise to push DTC programs as a ... Read More

Direct-to-consumer pharmacies seem great. But mail-order drugs come with hidden risks. | Opinion


The biggest recent news in prescription drugs was Pfizer's agreement to provide direct-to-consumer drug access through a partnership with President Donald Trump's administration. The impact of the ... Read More

Q&A: The economic forces that drive prescription drug prices


Luca Maini, assistant professor of health care policy in the Blavatnik Institute at Harvard Medical School, studies competition and regulation in pharmaceutical markets. He has studied how national ... Read More

Fact check: Trump’s lying spree about inflation


Trump claimed Friday: “We have almost no inflation. We’re down now to 2%.” He said at the same event: “Inflation is almost nonexistent.” Those claims are slightly more accurate than Trump’s ... Read More

Trump Aims To Cure High Medicine Prices, But Experts See Serious Side Effects To His Moves


Diccon Hyatt is an experienced financial and economics reporter who has covered the pandemic-era economy in hundreds of stories over the past two years. He's written hundreds of stories breaking down ... Read More

Trump announces deal to lower weight loss drug prices in some cases


The deal, with Eli Lilly and Novo Nordisk, is expected to lower the price of obesity drugs to between $149 and $350 per month in certain cases, officials said. Read More

Could direct-to-consumer drug pricing compete with prescription insurance?: Ohio State University


2025 OCT 21 (NewsRx) -- By a News Reporter-Staff News Editor at NewsRx Drug Daily-- COLUMBUS, Ohio - A new study offers a glimpse at how direct-to-consumer pharmacy pricing could one day present stiff ... Read More


Blow Us A Whistle


Comments (Whistles) Designed By Disqus